ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,393Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 1121

$1.1M Total Retail Price of All Prescriptions

Rank: 48 out of 1121

448 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 448 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

31% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,737 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 471 249 S3 1 3
FUROSEMIDE 449 331 2 7
LEVOTHYROXINE SODIUM 373 241 3 2
LISINOPRIL 295 178 4 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 290 185 5 31
GABAPENTIN 289 188 6 13
CYMBALTA 283 146 7 50
POTASSIUM CHLORIDE 282 186 8 12
SIMVASTATIN 265 183 9 1
CRESTOR 248 121 10 28
OMEPRAZOLE 243 151 11 6
ATORVASTATIN CALCIUM 237 117 12 15
AMLODIPINE BESYLATE 232 219 13 5
MELOXICAM 227 98 14 22
CARVEDILOL 210 97 15 20
DOXEPIN HCL 192 108 16 191
BYSTOLIC 189 71 17 121
RANITIDINE HCL 184 84 18 33
ATELVIA 176 126 19 264
WARFARIN SODIUM 175 141 20 11
AMITRIPTYLINE HCL 173 76 R 21 61
CYCLOBENZAPRINE HCL 168 27 R 22 83
CIPROFLOXACIN HCL 166 104 23 57
HYDROCHLOROTHIAZIDE 162 120 24 10
METFORMIN HCL 162 94 24 8
LOVASTATIN 161 88 26 26
NEXIUM 158 96 27 24
CELEBREX 156 116 28 104
ETODOLAC 156 69 28 211
JANUMET 150 84 30 167
AMOXICILLIN 144 58 31 140
SPIRONOLACTONE 141 83 32 54
ROPINIROLE HCL 138 57 33 91
CEPHALEXIN 137 59 34 111
PROMETHAZINE HCL 134 37 R 35 67
SYMBICORT 129 52 36 148
METOPROLOL TARTRATE 128 106 37 9
THEOPHYLLINE ANHYDROUS 123 69 38 175
LYRICA 117 43 39 76
MIRTAZAPINE 115 85 40 56
ACARBOSE 114 75 41 255
PHENYTOIN SODIUM EXTENDED 114 71 41 135
CITALOPRAM HBR 113 76 43 18
DIOVAN HCT 110 79 44 90
ATENOLOL-CHLORTHALIDONE 104 63 45 180
ALENDRONATE SODIUM 102 64 46 37
LIPITOR 102 62 46 106
NAMENDA 100 100 48 53
DEXILANT 98 33 49 136
TAMSULOSIN HCL 97 66 50 32
DIVALPROEX SODIUM 94 39 51 98
BUSPIRONE HCL 92 35 52 114
PROAIR HFA 92 40 52 48
ALLOPURINOL 88 64 54 30
DONEPEZIL HCL 88 82 54 35
LOSARTAN POTASSIUM 85 82 56 17
CLOPIDOGREL 85 55 56 27
RISPERIDONE 83 65 58 82
IBUPROFEN 83 0 58 110
SEROQUEL XR 83 42 58 236
QUETIAPINE FUMARATE 81 55 61 75
ISOSORBIDE MONONITRATE ER 81 28 61 62
PLAVIX 78 43 63 42
SPIRIVA 77 36 64 49
FAMOTIDINE 77 61 64 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 47 64 108
EXFORGE HCT 76 58 67 310
DICLOFENAC SODIUM 73 43 68 112
LEVOFLOXACIN 70 43 69 79
PRAVASTATIN SODIUM 67 56 70 14
PAROXETINE HCL 66 44 71 58
SERTRALINE HCL 64 55 72 21
KLOR-CON 10 63 50 73 69
TRAZODONE HCL 62 41 74 40
GLIPIZIDE XL 59 51 75 256
ZOLPIDEM TARTRATE 58 37 76 19
RANEXA 58 29 76 299
VENTOLIN HFA 56 31 78 92
AZITHROMYCIN 55 25 79 44
ADVAIR DISKUS 54 24 80 64
ATENOLOL 54 20 80 16
TRIAMTERENE-HCTZ 54 39 80 38
DOXYCYCLINE HYCLATE 53 30 83 103
DIGOXIN 52 29 84 59
BENZTROPINE MESYLATE 50 13 R 85 224
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.